Stacy L. Throm

568 total citations
19 papers, 434 citations indexed

About

Stacy L. Throm is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Stacy L. Throm has authored 19 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Genetics. Recurrent topics in Stacy L. Throm's work include Cancer therapeutics and mechanisms (7 papers), Glioma Diagnosis and Treatment (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Stacy L. Throm is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Glioma Diagnosis and Treatment (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Stacy L. Throm collaborates with scholars based in United States. Stacy L. Throm's co-authors include Clinton F. Stewart, Charles H. Fraga, Christopher M. Waters, Jun Shen, Vishal S. Narang, Narendra Kumar, Megan O. Jacus, Yogesh T. Patel, John C. Panetta and Michael J. Klemsz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Stacy L. Throm

19 papers receiving 430 citations

Peers

Stacy L. Throm

ONCOL

PPCH

PRM

GENET

Stefanie Reif Germany

M K Bowling United States

J. P. Eder United States

Shruthi Vaidhyanathan United States

Rebecca M. Ricklis United States

S. M. LUDEMAN United States

Kerrie Wilson United Kingdom

Andreas Hedblom United States

Valentina Rossi Italy

Janet Haasjes Netherlands

Stefanie Reif Germany

Stacy L. Throm

187 ×0.8

ONCOL

107 ×0.6

43 ×0.5

PPCH

51 ×0.8

PRM

83 ×1.5

GENET

Citations per year, relative to Stacy L. Throm Stacy L. Throm (= 1×) peers Stefanie Reif

Countries citing papers authored by Stacy L. Throm

Since Specialization

Citations

This map shows the geographic impact of Stacy L. Throm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacy L. Throm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacy L. Throm more than expected).

Fields of papers citing papers by Stacy L. Throm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacy L. Throm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacy L. Throm. The network helps show where Stacy L. Throm may publish in the future.

Co-authorship network of co-authors of Stacy L. Throm

This figure shows the co-authorship network connecting the top 25 collaborators of Stacy L. Throm. A scholar is included among the top collaborators of Stacy L. Throm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacy L. Throm. Stacy L. Throm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Patel, Yogesh T., Megan O. Jacus, Nidal Boulos, et al.. (2015). Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study. Cancer Chemotherapy and Pharmacology. 75(5). 897–906. 6 indexed citations

Jacus, Megan O., et al.. (2015). Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature. Clinical Pharmacokinetics. 55(3). 297–311. 37 indexed citations

Nandakumar, Satish K., et al.. (2015). Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice. Experimental Hematology. 43(7). 565–577.e10. 36 indexed citations

Jacus, Megan O., Richard J. Rahija, Abigail Davis, Stacy L. Throm, & Clinton F. Stewart. (2015). Observational Evaluations of Mice during Cerebral Microdialysis for Pediatric Brain Tumor Research.. PubMed. 54(3). 304–10. 2 indexed citations

Turner, David C., Fariba Navid, Najat C. Daw, et al.. (2014). Population Pharmacokinetics of Bevacizumab in Children with Osteosarcoma: Implications for Dosing. Clinical Cancer Research. 20(10). 2783–2792. 40 indexed citations

Jacus, Megan O., Stacy L. Throm, David C. Turner, et al.. (2013). Deriving therapies for children with primary CNS tumors using pharmacokinetic modeling and simulation of cerebral microdialysis data. European Journal of Pharmaceutical Sciences. 57. 41–47. 16 indexed citations

Turner, David C., et al.. (2013). Combination metronomic oral topotecan and pazopanib: a pharmacokinetic study in patients with gynecological cancer.. PubMed. 33(9). 3823–9. 10 indexed citations

Roberts, Michael S., David C. Turner, Abhijit Ramachandran, et al.. (2013). Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography–electrospray ionization-tandem mass spectrometry (LC–ESI-MS/MS). Journal of Chromatography B. 929. 1–5. 4 indexed citations

Elmeliegy, Mohamed, Stacy L. Throm, Fan Wang, et al.. (2012). Abstract 2742: Cerebral microdialysis for simultaneous sampling of crenolanib (PDGFR inhibitor) and erlotinib (EGFR inhibitor) in mouse models of glioma. Cancer Research. 72(8_Supplement). 2742–2742. 1 indexed citations

10.

Zhang, Fan, Stacy L. Throm, Laura A. Miller, et al.. (2011). MDM2 antagonist nutlin-3a reverses mitoxantrone resistance by inhibiting breast cancer resistance protein mediated drug transport. Biochemical Pharmacology. 82(1). 24–34. 22 indexed citations

11.

Elmeliegy, Mohamed, Ángel M. Carcaboso, Lionel M.L. Chow, et al.. (2011). Magnetic Resonance Imaging–Guided Microdialysis Cannula Implantation in a Spontaneous High-Grade Glioma Murine Model. Journal of Pharmaceutical Sciences. 100(10). 4210–4214. 7 indexed citations

12.

Elmeliegy, Mohamed, et al.. (2011). Abstract 5474: Optimization of a microdialysis method for evaluation of CP-868,596 penetration in glioblastoma murine models using a sensitive liquid chromatography mass spectrometry (LC-MS/MS) method. Cancer Research. 71(8_Supplement). 5474–5474. 1 indexed citations

13.

Zhang, Fan, Michael Tagen, Stacy L. Throm, et al.. (2010). Whole-Body Physiologically Based Pharmacokinetic Model for Nutlin-3a in Mice after Intravenous and Oral Administration. Drug Metabolism and Disposition. 39(1). 15–21. 46 indexed citations

14.

Narang, Vishal S., Charles H. Fraga, Narendra Kumar, et al.. (2008). Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. American Journal of Physiology-Cell Physiology. 295(2). C440–C450. 115 indexed citations

15.

Schaiquevich, Paula, John C. Panetta, Stacy L. Throm, et al.. (2008). Population pharmacokinetic (PK) analysis of gefitinib in pediatric cancer patients. Journal of Clinical Oncology. 26(15_suppl). 2523–2523. 5 indexed citations

16.

Stewart, Clinton F., John C. Panetta, Stacy L. Throm, et al.. (2007). UGT1A1Promoter Genotype Correlates With SN-38 Pharmacokinetics, but Not Severe Toxicity in Patients Receiving Low-Dose Irinotecan. Journal of Clinical Oncology. 25(18). 2594–2600. 69 indexed citations

17.

Stewart, Clinton F., John C. Panetta, Maureen O’Shaughnessy, et al.. (2006). UGT1A1 promoter genotype correlates with pharmacokinetics but not toxicity in patients receiving protracted irinotecan (IRN). Journal of Clinical Oncology. 24(18_suppl). 3078–3078. 1 indexed citations

18.

Throm, Stacy L. & Derek A. Persons. (2004). Regulation of Primitive Hematopoietic Cell Growth and Differentiation by the Gata-2 Transcription Factor.. Blood. 104(11). 2779–2779. 1 indexed citations

19.

Throm, Stacy L. & Michael J. Klemsz. (2003). PU.1 regulates glutathione peroxidase expression in neutrophils. Journal of Leukocyte Biology. 74(1). 111–117. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact